Boston-based research device developer 908 Devices completed its $125 million initial public offering, and its shares are now available to trade on the Nasdaq under the ticker "MASS." Shares are available for limit orders via Robinhood.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $14.46 |
|---|---|
| 52-week range | $13.08 - $79.60 |
| 50-day moving average | $24.17 |
| 200-day moving average | $34.61 |
| Wall St. target price | $55.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.30 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.46 from 2022-01-25
| 1 week (2022-01-20) | -4.43% |
|---|---|
| 1 month (2021-12-27) | -41.83% |
| 3 months (2021-10-27) | -54.81% |
| 6 months (2021-07-27) | -53.40% |
| 1 year (2021-01-27) | -73.05% |
|---|---|
| 2 years (2020-01-23) | N/A |
| 3 years (2019-01-23) | N/A |
| 5 years (2017-01-23) | N/A |
| Revenue TTM | $32.1 million |
|---|---|
| Gross profit TTM | $14.9 million |
| Return on assets TTM | -13.37% |
| Return on equity TTM | -44.85% |
| Profit margin | -90.18% |
| Book value | $4.41 |
| Market capitalisation | $480.7 million |
TTM: trailing 12 months
We're not expecting 908 Devices to pay a dividend over the next 12 months.
You may also wish to consider:
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. .
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.